3-spirocyclopropyl2-oxindole kinase inhibitors

Details for Australian Patent Application No. 2006269301 (hide)

Owner Allergan Inc.

Inventors Wurster, Julie A.

Agent Davies Collison Cave

Pub. Number AU-A-2006269301

PCT Pub. Number WO2007/008664

Priority 60/699,073 13.07.05 US

Filing date 10 July 2006

Wipo publication date 18 January 2007

International Classifications

C07D 209/96 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/404 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

25 October 2007 PCT application entered the National Phase

  PCT publication WO2007/008664 Priority application(s): WO2007/008664

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006269306-Torque limiting device

2006269298-Static free wet use chopped strands (WUC) for use in a dry laid process